Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 28, 2025 04:11 ET | Source: Research and Markets

North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America Mass Spectrometry Market Report by Product, Technology, End Use, Application, Countries and Company Analysis, 2025-2033" report has been...
November 24, 2025 17:16 ET | Source: Novartis Pharma AG

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III...
October 30, 2025 12:06 ET | Source: Research and Markets

Cell-Based Assay & High Content Screening Market Forecast 2025-2029: New Technologies Expand Applications of Cell-Based Assays in Research

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" has been added to...
October 28, 2025 09:00 ET | Source: MRIGlobal

MRIGlobal Achieves Perfect Score in U.S. Government Cybersecurity Certification

Kansas City, MO., Oct. 28, 2025 (GLOBE NEWSWIRE) -- MRIGlobal is proud to announce that following an independent and rigorous C3PAO assessment, its Arcus CUI (Controlled Unclassified Information)...
October 21, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Advocates to Congress on November 4: Every Moment Matters in the Fight Against Muscle Loss

Washington, D.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) will bring nearly 100 advocates, scientists, and families living with neuromuscular diseases to Capitol...
October 15, 2025 09:00 ET | Source: Muscular Dystrophy Association

Agenda Announced for 2026 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease

New York, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the agenda including tracks and chairs for the 2026 MDA Clinical & Scientific Conference...
September 19, 2025 04:23 ET | Source: Research and Markets

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application,...
September 09, 2025 01:00 ET | Source: Novartis Pharma AG

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular diseasePacibekitug is a promising...
August 30, 2025 11:00 ET | Source: Novartis Pharma AG

Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C) goals early with reduced muscle pain1 85% of...
August 29, 2025 04:21 ET | Source: Research and Markets

Life Science Analytics Company Benchmark Analysis Report 2025 | Oracle, Accenture, and IQVIA Lead with Cloud-Based Solutions, Strategic Partnerships, and Advanced Data Integration

Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "Life Science Analytics - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering.The Life Science Analytics...